Project Details
| Short title | 1397-0017 |
|---|---|
| Acronym | Clairleaf |
| Status | Active |
| Effective start/end date | 28/04/24 → 19/03/29 |
CTU: A randomised, double-blind, parallel group, roll-over study evaluating long-term safety and efficacy of oral doses of BI 1291583 q.d. (Part A) followed by open label long-term safety assessment (Part B) in patients with bronchiectasis (ClairleafTM)
- Morgan, Lucy (Primary Chief Investigator)
- Martin, Lewis (Clinical Trial Unit Staff)
- TAIDI, Gina (Clinical Trial Unit Staff)
- Chapman, Nicola (Clinical Trial Unit Staff)
Project: Research